2‐Deoxyglucose Enhances 1‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine‐Induced ATP Loss in the Mouse Brain
- 1 August 1993
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 61 (2) , 610-616
- https://doi.org/10.1111/j.1471-4159.1993.tb02165.x
Abstract
The effects of 2‐deoxyglucose (2‐DG), an inhibitor of the uptake and use of glucose, on ATP loss caused by the neurotoxicant 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) were determined in the mouse brain. 2‐DG alone had no effect on brain ATP levels, but when administered 30 min before MPTP exposure, 2‐DG significantly enhanced MPTP‐induced ATP reduction. This was reflected as an increase in ATP loss in the striatum (from 15 to 27%) as well as a significant decrease in ATP in the cerebellar cortex, an area of the brain that was not affected after exposure to MPTP alone. In mice pretreated with 2‐DG, striatal ATP levels remained significantly decreased for >8 h after MPTP administration. In contrast, ATP levels in the cerebellar cortex returned to normal values within 4 h from MPTP exposure. Mazindol, a catecholamine uptake blocker, completely protected against MPTP‐induced loss of striatal ATP in the absence of 2‐DG, but it only partially prevented striatal ATP decrease after administration of both 2‐DG and MPTP; mazindol was also ineffective in protecting against ATP loss caused by 2‐DG and MPTP in the cerebellar cortex. 2‐DG/MPTP‐induced ATP loss appeared to be associated with the presence of the 1 ‐methyl‐4‐phenylpyridinium (MPP+) metabolite because (1) the pattern of ATP recovery in the striatum and cerebellar cortex appeared to reflect the pattern of MPP+clearance from these areas of the brain (i.e., significant MPP+ levels persisted longer in the striatum than in the cerebellar cortex), and (2) ATP decrease was completely prevented by blocking the conversion of MPTP to MPP+with the monoamine oxidase B inhibitor deprenyl. Data indicate that impairment of glucose metabolism dramatically enhances the effects of MPTP/MPP+ on cerebral energy supplies, making these effects relatively nonselective for dopaminergic neurons of the nigrostriatal pathway.Keywords
This publication has 34 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetaldehydehyde or diethyldithiocarbamateNeurochemistry International, 1992
- Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 1992
- Mechanism of Accumulation of the 1‐methyl‐4‐Phenylpyridinium Species into Mouse Brain SynaptosomesJournal of Neurochemistry, 1991
- The effects of monoamine oxidase inhibition and dopamine uptake blockade on MPTP-induced increase of 2-[3H]deoxyglucose uptake in specific mesencephalic catecholaminergic nucleiNeuroscience Letters, 1990
- Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatumBrain Research, 1989
- Fructose prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced ATP depletion and toxicity in isolated hepatocytesBiochemical and Biophysical Research Communications, 1988
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehydeLife Sciences, 1987
- 1-methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in cultureNeuroscience Letters, 1985
- Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomesBiochemical and Biophysical Research Communications, 1985